The U.S. Department of Health & Human Services (HHS), National Institutes of Health (NIH), Clinical Center (CC) requires the renewal of its Theradoc Clinical Surveillance and Decision Support System. This Statement of Work (SOW) outlines the need to continue utilizing the Theradoc platform to support patient safety, infection prevention, antimicrobial stewardship, and regulatory compliance by aggregating and analyzing data from various clinical systems. The contractor will be responsible for renewing existing on-premises software licenses, providing maintenance, patching, support services, updates, upgrades, and security patches, as well as supporting existing interfaces and providing training. Deliverables include license renewal confirmation, ongoing software updates, quarterly support reports, and training sessions. The government will provide necessary network access and documentation. The contractor must comply with federal security requirements, including FISMA and NIST SP 800-53. The period of performance for this firm-fixed-price contract is from October 1, 2025, to September 30, 2026, with two additional 12-month option periods.
This Statement of Work outlines the National Institutes of Health (NIH) Clinical Center's requirement for the renewal of Premier Healthcare TheraDoc license subscriptions and support. The NIH Clinical Center, a 200-bed biomedical research hospital, utilizes TheraDoc's Infection Control Assistant for real-time surveillance and alerts regarding healthcare-associated infections. The renewal seeks to continue this critical function, with potential future enhancements including new modules for Pharmacy use. The vendor will provide annual subscriptions for the Infection Control Assistant and Pharmacy Assistant, along with implementation services for system upgrades and new features. The contract specifies detailed maintenance and support requirements, including Service Level Agreements (SLAs) for response and fix times based on problem severity, and a licensing agreement for software and custom products. The period of performance includes a base year from October 1, 2025, to September 30, 2026, with two option years. All deliverables must be received in full working order at the NIH Clinical Center in Bethesda, MD.